SunTrust Robinson analyst John Boris reiterated a Buy rating on Merck & Company (NYSE: MRK) on August 14 and set a price target of $77. The company’s shares opened today at $67.60, close to its 52-week high of $69.
According to TipRanks.com, Boris is a 4-star analyst with an average return of 10.9% and a 68.1% success rate. Boris covers the Healthcare sector, focusing on stocks such as Avadel Pharmaceuticals plc, Jazz Pharmaceuticals, and Eli Lilly & Co.
Currently, the analyst consensus on Merck & Company is a Strong Buy with an average price target of $68.80.
See today’s analyst top recommended stocks >>
The company has a one-year high of $69 and a one-year low of $52.83. Currently, Merck & Company has an average volume of 9.08M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
